Cowen Positive on Teladoc (TDOC) on First Cross-Sell with Livongo
Tweet Send to a Friend
Cowen analyst Charles Rhyee reiterated an Outperform rating and $262 price target on Teladoc (NYSE: TDOC) after the announcement that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


